Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Biomaterials
|
October 4, 2011
Oh the irony: Iron as a cancer cause or cure?
Susan P Foy, Vinod Labhasetwar
Pharmaceutical Research
|
September 17, 2010
PEG-functionalized magnetic nanoparticles for drug delivery and magnetic resonance imaging applications
Murali Mohan Yallapu, Susan P Foy, Tapan K Jain, et al.
Molecular Pharmaceutics
|
September 28, 2010
Tumor ablation and nanotechnology
Rachel L Manthe, Susan P Foy, Nishanth Krishnamurthy, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons
|
September 4, 2004
The impact of third molar symptoms, pain, and swelling on oral health-related quality of life
Gary D Slade, Susan P Foy, Daniel A Shugars, et al.
Biomaterials
|
September 22, 2009
Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice
Tapan K Jain, Susan P Foy, Bernadette Erokwu, et al.
ACS Nano
|
August 25, 2010
Optical imaging and magnetic field targeting of magnetic nanoparticles in tumors
Susan P Foy, Rachel L Manthe, Steven T Foy, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons
|
December 31, 2003
The impact of intravenous antibiotics on health-related quality of life outcomes and clinical recovery after third molar surgery
Susan P Foy, Daniel A Shugars, Ceib Phillips, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons
|
January 7, 2005
The impact of intravenous corticosteroids with third molar surgery in patients at high risk for delayed health-related quality of life and clinical recovery
Paul S Tiwana, Susan P Foy, Daniel A Shugars, et al.
Journal for Immunotherapy of Cancer
|
October 21, 2014
Elucidating immunologic mechanisms of PROSTVAC cancer immunotherapy
Stefanie J Mandl, Ryan B Rountree, Tracy B Dela Cruz, et al.
Plos One
|
February 25, 2016
Poxvirus-Based Active Immunotherapy with PD-1 and LAG-3 Dual Immune Checkpoint Inhibition Overcomes Compensatory Immune Regulation, Yielding Complete Tumor Regression in Mice
Susan P Foy, Barbara Sennino, Tracy dela Cruz, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Biomaterials
|
October 4, 2011
Oh the irony: Iron as a cancer cause or cure?
Susan P Foy, Vinod Labhasetwar
Pharmaceutical Research
|
September 17, 2010
PEG-functionalized magnetic nanoparticles for drug delivery and magnetic resonance imaging applications
Murali Mohan Yallapu, Susan P Foy, Tapan K Jain, et al.
Molecular Pharmaceutics
|
September 28, 2010
Tumor ablation and nanotechnology
Rachel L Manthe, Susan P Foy, Nishanth Krishnamurthy, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons
|
September 4, 2004
The impact of third molar symptoms, pain, and swelling on oral health-related quality of life
Gary D Slade, Susan P Foy, Daniel A Shugars, et al.
Biomaterials
|
September 22, 2009
Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice
Tapan K Jain, Susan P Foy, Bernadette Erokwu, et al.
ACS Nano
|
August 25, 2010
Optical imaging and magnetic field targeting of magnetic nanoparticles in tumors
Susan P Foy, Rachel L Manthe, Steven T Foy, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons
|
December 31, 2003
The impact of intravenous antibiotics on health-related quality of life outcomes and clinical recovery after third molar surgery
Susan P Foy, Daniel A Shugars, Ceib Phillips, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons
|
January 7, 2005
The impact of intravenous corticosteroids with third molar surgery in patients at high risk for delayed health-related quality of life and clinical recovery
Paul S Tiwana, Susan P Foy, Daniel A Shugars, et al.
Journal for Immunotherapy of Cancer
|
October 21, 2014
Elucidating immunologic mechanisms of PROSTVAC cancer immunotherapy
Stefanie J Mandl, Ryan B Rountree, Tracy B Dela Cruz, et al.
Plos One
|
February 25, 2016
Poxvirus-Based Active Immunotherapy with PD-1 and LAG-3 Dual Immune Checkpoint Inhibition Overcomes Compensatory Immune Regulation, Yielding Complete Tumor Regression in Mice
Susan P Foy, Barbara Sennino, Tracy dela Cruz, et al.
Page
of 2